Related Experiment Video
Updated: Feb 14, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Obesity Does Not Influence the Outcomes of Minimally Invasive Mitral Valve Repair for Mitral Regurgitation: A
Piotr Mazur1,2, Ibrahim Gadelkarim1, Mateo Marin-Cuartas1
1University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig 04289, Germany.
Objectives:
Data on the role of obesity in patients undergoing minimally invasive cardiac surgery are sparse, and the longitudinal observations after minimally invasive mitral valve repair (MI-MVr) in obese patients are lacking.
Methods:
This retrospective propensity-score-matched analysis compared the outcomes of MI-MVr in obese patients (body mass index [BMI] ≥30 kg/m2), with those in individuals with normal body weight (BMI 19-25 kg/m2), focusing on overall survival.
Results:
In 501 analysed matched pairs, BMI ranged 30-60 kg/m2 in obese group and 19-24.9 kg/m2 in normal-BMI group. There were no baseline differences among matched cohorts, except for higher incidence of hypertension (78% vs 57%, P < .001) and hypercholesterolaemia (35% vs 28%, P = .02) in obese patients, and slightly worse renal function. All patients received MI-MVr through right lateral mini-thoracotomy. The median total operative time (by 11 minutes) and cardiopulmonary by-pass time (by 5 minutes) were longer in obese patients (P = .001), but the cross-clamp times did not differ. There were no intergroup differences in the early complication rates or hospitalization lengths. After a median follow-up of 9.3 years, the overall survival was similar. Actuarial survival at 15 years was 59% for obese patients and 57% for those with normal BMI (log-rank, P = .38). A multivariable model identified diabetes (HR [95% CI], 1.65 [1.26-2.16], P = .0003), chronic lung disease (1.81 [1.31-2.51], P = .0004), left ventricular ejection fraction (LVEF) <50% (2.28 [1.78-2.93], P ≤ .0001), and older age (1.08 [1.07-1.10], P ≤ .0001) as independent predictors of mortality.
Conclusions:
Obesity alone does not influence the outcomes of MI-MVr, but diabetes, chronic lung disease, and impaired pump function do affect the overall survival.
Insights
Obesity does not impact outcomes after minimally invasive mitral valve repair (MI-MVr). However, conditions like diabetes, chronic lung disease, and reduced left ventricular ejection fraction significantly affect long-term survival in these patients.
Area of Science:
- Cardiovascular Surgery
- Obesity Medicine
- Surgical Outcomes Research
Background:
- Limited data exist on the long-term effects of obesity in patients undergoing minimally invasive cardiac surgery.
- Longitudinal outcomes after minimally invasive mitral valve repair (MI-MVr) in obese individuals are not well-documented.
Purpose of the Study:
- To compare the overall survival rates of obese patients versus normal-weight patients after MI-MVr.
- To identify factors influencing long-term mortality in patients who have undergone MI-MVr.
Main Methods:
- A retrospective analysis utilizing propensity-score matching.
- Comparison of outcomes between obese (body mass index [BMI] ≥30 kg/m2) and normal-weight (BMI 19-25 kg/m2) patients who underwent MI-MVr.
- Median follow-up of 9.3 years, with actuarial survival assessed at 15 years.
Main Results:
- No significant differences in overall survival were observed between obese and normal-weight patients at 15 years (59% vs. 57%).
- Obese patients had slightly longer operative and cardiopulmonary bypass times but similar cross-clamp times and early complication rates.
- Independent predictors of mortality included diabetes, chronic lung disease, left ventricular ejection fraction <50%, and older age.
Conclusions:
- Obesity itself is not a significant determinant of outcomes following MI-MVr.
- Comorbidities such as diabetes, chronic lung disease, and impaired cardiac function are critical factors affecting long-term survival after MI-MVr.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

